Cargando…
Probing the mechanism of cardiovascular drugs using a covalent levosimendan analog
One approach to improve contraction in the failing heart is the administration of calcium (Ca(2 +)) sensitizers. Although it is known that levosimendan and other sensitizers bind to troponin C (cTnC), their in vivo mechanism is not fully understood. Based on levosimendan, we designed a covalent Ca(2...
Autores principales: | Pineda-Sanabria, Sandra E., Robertson, Ian M., Sun, Yin-Biao, Irving, Malcolm, Sykes, Brian D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831045/ https://www.ncbi.nlm.nih.gov/pubmed/26853943 http://dx.doi.org/10.1016/j.yjmcc.2016.02.003 |
Ejemplares similares
-
Defining the Binding Site of Levosimendan and Its Analogues in a Regulatory Cardiac Troponin C−Troponin I Complex
por: Robertson, Ian M., et al.
Publicado: (2008) -
Levosimendan: A Cardiovascular Drug to Prevent Liver Ischemia-Reperfusion Injury?
por: Onody, Peter, et al.
Publicado: (2013) -
The structural and functional effects of the familial hypertrophic cardiomyopathy-linked cardiac troponin C mutation, L29Q
por: Robertson, Ian M., et al.
Publicado: (2015) -
Multiorgan Drug Action of Levosimendan in Critical Illnesses
por: Pan, Jian, et al.
Publicado: (2019) -
Does the cardiovascular drug levosimendan prevent iodinated contrast medium nephrotoxicity with glycerol aggravation in rats?
por: Durur-Subasi, Irmak, et al.
Publicado: (2021)